Subsequently, the migration and invasion abilities of the 231 and 549 cells was reduced when SLC25A32 was downregulated in triple-negative breast cancer (TNBC) cells (Figure 10(a)–10(c)), indicating that SLC25A32 can affect the biological functions of TNBC cells proliferation and migration. Here, SLC25A32 is linked to triple-negative breast carcinoma.